🇺🇸 FDA
Patent

US 10416174

Diagnosis and prognosis for chronic fatigue syndrome

granted A61KA61K38/00

Quick answer

US patent 10416174 (Diagnosis and prognosis for chronic fatigue syndrome) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00